Date published: 2026-4-27

1-800-457-3801

SCBT Portrait Logo
Seach Input

PSMD7 Inhibitors

PSMD7, also known as the 26S proteasome non-ATPase regulatory subunit 7, is a pivotal component of the 26S proteasome complex, which plays an essential role in the ubiquitin-proteasome system (UPS). The UPS is critical for the regulated degradation of ubiquitinated proteins, thereby maintaining cellular homeostasis through the removal of misfolded, damaged, or regulatory proteins. PSMD7 contributes to the assembly and functional integrity of the 19S regulatory particle, facilitating the recognition, unfolding, and translocation of target proteins into the 20S core proteolytic chamber. This process is crucial for cell cycle regulation, signal transduction, and stress response mechanisms, among others. By influencing the degradation rate of various substrates, PSMD7 indirectly modulates numerous cellular processes, including apoptosis, metabolism, and DNA repair. The precise control over protein degradation executed by the proteasome, with PSMD7 as a key regulatory subunit, underscores the importance of this system in sustaining cellular physiology and response to environmental cues.

The inhibition of PSMD7, and thereby the proteasome function, involves mechanisms that can interfere with the assembly, stability, or activity of the 26S proteasome complex. One approach includes the disruption of the interaction between PSMD7 and other proteasomal subunits or regulatory factors, which is critical for the correct assembly and recruitment of the regulatory particle to the proteolytic core. Such interference can impede the proper formation of the proteasome complex, affecting its ability to recognize and degrade ubiquitinated substrates. Another mechanism involves direct inhibition of the functional domains within PSMD7 that are responsible for substrate recognition or interaction with ubiquitin chains, thereby blocking the translocation of targeted proteins into the proteolytic chamber. Additionally, post-translational modifications of PSMD7, such as phosphorylation or ubiquitination, can modulate its activity or stability, leading to altered proteasome function. These inhibitory strategies highlight the complex regulation of the UPS and underscore the significance of PSMD7 within this system for controlling protein turnover and maintaining cellular homeostasis.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Bortezomib binds to the 20S core of the proteasome with high affinity and specificity, inhibiting its proteolytic function.

Carfilzomib

868540-17-4sc-396755
5 mg
$41.00
(0)

Carfilzomib irreversibly binds to the N-terminal threonine-containing active sites of the 20S proteasome, inhibiting its activity.

Ixazomib

1072833-77-2sc-489103
sc-489103A
10 mg
50 mg
$311.00
$719.00
(0)

Ixazomib selectively and reversibly inhibits the 20S proteasome's chymotrypsin-like activity.

Oprozomib

935888-69-0sc-477447
2.5 mg
$280.00
(0)

Oprozomib is a proteasome inhibitor that targets the CT-L activity of the proteasome.

Delanzomib, free base

847499-27-8sc-396774
sc-396774A
5 mg
10 mg
$160.00
$300.00
(0)

Delanzomib is a boronic acid-based proteasome inhibitor that targets and inhibits the chymotrypsin-like activity of the proteasome.

Epoxomicin

134381-21-8sc-201298C
sc-201298
sc-201298A
sc-201298B
50 µg
100 µg
250 µg
500 µg
$137.00
$219.00
$449.00
$506.00
19
(2)

Epoxomicin is a natural product that selectively inhibits the chymotrypsin-like activity of the proteasome.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

MG-132 is a peptide aldehyde that reversibly inhibits the proteasome's chymotrypsin-like and peptidylglutamyl-peptide hydrolyzing activity.

Lactacystin

133343-34-7sc-3575
sc-3575A
200 µg
1 mg
$188.00
$575.00
60
(2)

Lactacystin is a naturally occurring lactone that irreversibly inhibits proteasome activity by binding to its active site threonine.